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1. Introduction
Recent decades have seen a growth in travel and tourism abroad because of cheap air fares and 
holiday packages. This has been accompanied by a relaxation of border controls, especially within 
parts of Europe participating in the Schengen Agreement. As some people may be more inclined to use 
illicit substances during holiday periods and some may even choose to travel to destinations that are 
associated with drug use — a phenomenon sometimes referred to as ‘drug tourism’ — this means that 
from a European drug policy perspective the issue of drug use and travel has become more important.
This Thematic paper examines travellers and drug use, with a focus on Europeans travelling within 
Europe, although some other relevant destinations are also included. For the purpose of this 
publication, a ‘traveller’ is defined as someone who goes abroad for reasons ranging from a 
weekend visit to a music festival or a short holiday, through to backpacking for longer periods.
Using drugs in a foreign country can be associated with additional risks and consequences. For 
example, while drug use anywhere may lead to adverse health consequences, using drugs abroad 
can be associated with increased risks due to additional uncertainties regarding the composition 
and purity of the substances and the lack of knowledge of local health and social services. In 
addition, under the influence of drugs, tourists may also engage in behaviours that put them at risk 
of various medical conditions, accidents and risky sexual practices. They also risk arrest and 
imprisonment for possessing, using, selling or smuggling drugs into and out of a country. Local 
populations may also be negatively affected. While visitors bring income to the host countries, drug 
use by some may lead to antisocial behaviour and public nuisance, an increase in those requiring 
health and social services, and the presence of gangs controlling the drug trade, thus putting 
pressure on the local law enforcement, health and social services.
Little is known about the issue of drug use by travellers. This Thematic paper seeks to increase the 
interest in this topic both in terms of research and of developing adequate responses to problems 
related to drugs and travel. The paper aims to shed some light on this topic by investigating the 
following five questions:
What is the profile of those who travel and use drugs?
Which destinations have been associated with drug use among travellers?
What is the prevalence of drug use among travellers?
What are the risks associated with using drugs while travelling?
What is the potential for prevention interventions?
Information for this publication was collected from online reference resources, such as PubMed and 
Scopus, and with the help of Internet search engines. In addition, six Reitox national focal points (1) 
provided information about drugs and travel in their countries and about drug use among their 
citizens while the latter are travelling. These countries are presented as examples in the following 
pages but they should not be considered as necessarily having more extensive travel and drug use 
problems than other European countries.
(1) The Czech Republic, Greece, Spain, France, Cyprus and Croatia.
emcdda.europa.eu
4Travel and drug use in Europe: a short review
2. Travelling and using drugs
This section briefly introduces two population groups who are susceptible to use drugs while 
travelling: young people and problem drug users. Of course, belonging to one or both of these 
groups does not necessarily lead to drug use while travelling.
Young people
According to a report published by the World Tourism Organization (Richards, 2008), youth travel (2) 
has become a major part of the tourist industry, and, over the last decade, both the length of time 
young people spend away and their spending as a proportion of income have increased. In 2008, 
youth travel accounted for an estimated 20 % of a total of 160 million international tourist arrivals (3). 
For example, Croatia — a country with 4.3 million inhabitants — registered 48.8 million foreign 
tourists in 2010. The average age of the tourists was 41 years, and 19 % were under the age of 30.
Young travellers, however, are not a homogeneous group and their travelling style is one of the 
factors that may differentiate them. For example, one group of young travellers on short or 
sometimes extended trips are those who travel around carrying their belongings in a backpack. 
Many backpackers live on a low budget and some may seek employment while travelling. With the 
increase in youth travel, backpacking gained momentum in the 1990s to such an extent that it has 
now become mainstream among many young people. Backpackers vary, however, for instance in 
nationality, age, gender, stage in their life cycle and motivation for travelling. A relatively small 
group adopt the travelling lifestyle for years. These so-called ‘drifters’ (4) are similar to members of 
the hippie counterculture of the 1960s to the 1970s in their departure from the lifestyles of 
mainstream society (Cohen, 2011).
Problem drug users
Problem drug use is defined by the EMCDDA as injecting drug use or long-duration/regular use of 
opioids, cocaine and/or amphetamine. According to Focal Point reports, there are several reasons 
why problem drug users may travel to another country, such as to:
•   access drug treatment programmes or harm reduction services (such as needle exchanges or 
injecting rooms) that
•   – are unavailable in their home countries or
•  –  have opening hours that are more convenient for drug users who are employed or
•  –  will enable them to hide their problem drug use or escape from their social environment 
because of the geographical distance;
(2)  Young people were defined in that report as those aged 16–29, although certain sections of the report presented 
data referring to other age groups.
(3) In addition, youth lifestyles, including travelling, are also found among older age groups.
(4) Not only backpackers, but also ocean yacht cruisers and caravanners.
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•   escape legal and social problems connected with their drug use;
•   carry out illegal activities related to their drug use (such as dealing); and/or
•   access drugs that are expensive or unavailable in their home countries.
Most problem drug users, however, have limited financial means. Travelling for longer duration or 
distances, therefore, may be proportionately more likely among socially integrated than socially 
marginalised drug users (Gyarmathy and Neaigus, 2005).
Information is scarce on problem drug users travelling to access treatment, which may reflect the 
fact that this type of travel is relatively limited. Several examples, however, have been provided by 
reporting countries that indicate that this phenomenon does exist. For example, the focal point in 
Cyprus reported that 30 nationals from Greece received treatment, including detoxification with 
Suboxone (buprenorphine and naloxone) and naltrexone implants, at a therapeutic programme in 
Cyprus in 2010. Some problem drug users from France (including those from non-border areas) 
reportedly travel to Belgium to obtain treatment with methadone. These include professionals who 
travel abroad for purposes of discretion, or because the opening hours of French treatment centres 
are inconvenient for those who have working hours with limited flexibility. There are also reports 
that about one in five clients of the safer injecting facility in the German city of Saarbrücken is a 
French national. Although they cannot officially access the centre, their presence is tolerated. Some 
Hungarian injecting drug users are sent by their families to receive treatment in western Europe in 
order to break off social ties with their injecting friends (Gyarmathy and Neaigus, 2005).
In addition to travelling to other countries within Europe, problem drug users may travel within their 
country or to destinations outside Europe. For example, socially marginalised injecting drug users 
may travel extensively within Hungary during poppy season around May and September to milk 
poppies and make their own drugs (a phenomenon referred to by drug users as ‘country tourism’), 
to participate in residential drug treatment or to visit relatives (Gyarmathy and Neaigus, 2005). 
Lithuanian drug users who inject liquid drugs travel from Vilnius to surrounding settlements in order 
to purchase cheap drugs in pre-loaded syringes (Gyarmathy et al., 2010). Some of the injecting 
drug users in a drug treatment programme in Slovenia (Kostnapfel et al., 2011) reported travelling 
to distant locations, such as Asia or America. The majority had obtained a medical certificate to be 
allowed to transport their substitution medications.
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3. Examples of drug-related destinations
Certain groups of travellers may seek out destinations with the specific goal of either using drugs or 
engaging in activities that involve drug use (5). Such locations include those where drugs are more 
available than in the home country or that are famous for their music festivals, clubs and party 
scenes. Focal points report that problem drug users may choose certain destinations because those 
destinations offer drug treatment and/or harm reduction services that are unavailable in their home 
countries or to distance themselves from their drug-using friends. 
Amsterdam in the Netherlands and Prague in the Czech Republic are sometimes mentioned as 
examples of European destinations where travellers may use drugs. According to media 
reports (6), Amsterdam receives 4.5 million tourists from abroad annually, about a quarter of 
whom visit coffee shops. These are establishments where patrons can purchase cannabis for 
personal consumption. About a quarter of Dutch municipalities have at least one coffee shop, 
although the number of shops has dramatically decreased in recent years — from about 1 200 
in 1997 to about 640 in 2011. It is also foreseen that, in the near future, Dutch coffee shops will 
no longer be accessible to travellers from foreign countries (see below). According to the Czech 
national focal point, Prague is sometimes referred to as ‘little Amsterdam’ by people who travel 
there with the purpose of obtaining methamphetamine (Pervitin). Drug users from neighbouring 
countries (especially Germany and Slovakia) visit Prague and border areas to procure this drug 
and then return to their home countries with quantities not exceeding the legal threshold for 
personal use in the Czech Republic.
Ibiza, one of the Spanish Balearic Islands, is referred to as the party capital of the world for its 
lively electronic music scene. Since the late 1980s, top DJs within the electronic dance music genres 
of house, trance and techno have come to the island to play at various clubs, attracting crowds of 
young people from around the globe who love dancing and partying and who, in some cases, also 
use legal or illegal substances. In addition to Ibiza, several other locations and cities throughout 
Europe — such as Amsterdam, Athens, Barcelona, Berlin, Budapest, Munich and Mykonos — are 
dubbed ‘party capitals’.
In many countries, there is a large variety of music festivals featuring all musical styles (see Box 
‘Examples of European music festivals’). Many of these festivals are several days long and attract 
tens or even hundreds of thousands of visitors from different countries. Several holiday locations in 
Europe also attract young people to a busy nightlife scene comprising many clubs, hosted by top 
disc jockeys (DJs). Some young people may extend their time abroad by mixing holiday travel with 
paid casual work in foreign bars and nightclubs (Hughes et al., 2004).
(5)  The term ‘alcotourism’, for example, refers to trips made for the main reason of drinking — often excessive 
quantities of — alcohol (Bell, 2008). Some holiday destinations are promoted for their possibilities of or 
permissiveness towards excessive drinking.
(6) www.rnw.nl/english/article/foreigners-not-welcome-coffee-shops
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Examples of European music festivals
Some of the most popular and best-known music festivals and parades in Europe are the Donauinselfest in 
Vienna, Austria, featuring an extremely broad range of musical genres and hosting an estimated 3 million 
visitors; the Zurich Street Parade in Switzerland in August; and the Lake Parade in Geneva, also Switzerland, 
in July. The last two report around a million visitors each.
There is also a range of large electronic music festivals across Europe, such as the Paris Techno Parade in 
France in September with half a million visitors; the Sziget (Island) Festival in Budapest, Hungary, in August 
with about 400 000 visitors; the Exit festival in Serbia with about 200 000 visitors; the Glastonbury festival in 
the UK with about 130 000 visitors; the Sonar Festival in Barcelona, Spain, in June with about 85 000 visitors; 
the Fusion (Фузион) Festival on the former military airfield in Lärz, Germany, with 60 000 visitors; Nature 
One with over 60 000 visitors in the Frankfurt area in Germany; the Monegros Festival in the desert of Spain 
in June with about 40 000 visitors; the Loveland Festival near Amsterdam in the Netherlands with about 
20 000 visitors; and Love Family Park in the Frankfurt area of Germany with about 15 000 visitors. The 
Outlook Festival in Croatia is recognised in its fifth year as Europe’s largest bass music and sound system 
culture festival. At many of these events, the majority of visitors are not local, but from abroad.
Crossing borders to attend nightlife events or music festivals is common in different parts of 
Europe. For example, information provided by the French national focal point indicates that, 
because of longer operating hours, less rigorous enforcement of age restrictions and, sometimes, 
cheaper drugs available in the neighbouring countries of Belgium and Germany, a majority of 
drug users and drug dealers at some events in these countries can be French nationals. They 
represented, for example, about 70 % of people arrested for drug use in music venues in the 
district of Tournai in Belgium in 2010. French dealers who specialise in supplying the mostly 
French party crowd with large amounts of drugs have also reportedly replaced the drug users 
who sold small quantities to fund their partying. On the southern side of the country, trips to 
Spain — mainly Barcelona — to attend large electronic music events are viewed as an initiation 
rite for many young people from Toulouse (the French city nearest to Spain), whereas during the 
grape harvest many Spanish party enthusiasts travel to the Bordeaux area for open-air 
gatherings in rural areas.7
Policing the party scene
The ‘Free Party Movement’ started in the United Kingdom in the 1980s, and grew from smaller dance events to 
large techno-parties or raves, associated with the use of ecstasy. A week-long party with 25 000 people in 
Worcestershire in England, however, resulted in great public outrage and strong legal regulations governing 
such events (7). This was followed by an internationalisation of the music scene with parties being held ever 
more widely across Europe, and people travelling across borders to participate. Legal sanctions to curb the 
sometimes out-of-control parties were also used in other countries but they often pushed them across borders 
within Europe. For instance, the purpose of the French application order of 2002-887 (Mariani et Vaillant) was 
to break down large parties into relatively smaller ones, but it also sent many of the events and their visitors to 
neighbouring countries such as Spain and Germany.
(7)  According to the UK focal point, however, raves have again become increasingly popular in the past 5 years in 
the UK, with at least one of them happening a week in London.
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Party destinations exist outside Europe as well. For example, the state of Goa in India became one 
such place during the 1970s and 1980s and turned from a ‘hippie paradise’ to a party scene, with 
trance and rave music (Saldanha, 2001). These parties typically take place in the northern Goa 
beach areas, with media reports of organised crime groups supplying drugs to an international 
group of young people (8). In addition, certain beaches in Thailand are also popular party 
destinations.
(8) http://articles.timesofindia.indiatimes.com/2011-01-24/goa/28372846_1_foreigners-russian-mafia-sunburn
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4. Prevalence of drug use among young travellers
Drug use surveys among travellers are not plentiful. Only a few research groups in Europe study the 
issue, and those that do tend to concentrate on young people. This section examines the prevalence 
of drug use among European holidaymakers aged 16–35, young backpackers, and young 
clubbers and partygoers.
Young holidaymakers in Europe
A research group in the United Kingdom has conducted extensive and repeated studies on young 
European travellers and their drug-using behaviour (Bellis et al., 2003, 2007, 2009; Hughes et al., 
2004, 2008, 2009, 2011). One of the group’s recent studies (Hughes et al., 2011) was among 
British and German holidaymakers (the highest proportion of international visitors to the 
Mediterranean) in airports in Cyprus, Greece, Italy, Portugal and Spain. Researchers approached 
all individuals who appeared to be aged 16–35 and who were travelling without children or older 
relatives. Of these, about two-thirds agreed to complete an anonymous self-administered 
questionnaire, giving a fairly unbiased sample of over 6 500 holidaymakers who travel by air to 
Mediterranean holiday destinations. Results included:
•   About one in five participants reported the use of illicit drugs at least once in the past 12 months 
in their home countries (12 % reported using cannabis only and 8 % reported using other drugs), 
with higher prevalence rates among UK than German nationals.
•   One in ten reported the use of illicit drugs during their holiday. Among those who used illicit 
drugs while on holiday, 87 % had used cannabis, 32 % ecstasy, 18 % cocaine, 6 % ketamine, 
6 % amphetamine and 4 % gamma-hydroxybutyric acid (GHB). The prevalence of drug use 
varied by travel destination, but differences between UK and German nationals were less 
pronounced than at home.
•   Alcohol was used by almost all the holidaymakers (95 %), with 78 % of UK nationals and 61 % 
of Germans reporting that they had been drunk at least once during their stay. Furthermore, 
regular drunkenness (being drunk on at least half of the days of stay) was common, reported by 
45 % of UK nationals and 24 % of Germans.
Another study combined cross-sectional survey methods with ethnographic fieldwork to assess 
excessive drinking and drug use among over 1 000 young Danish holidaymakers in Bulgaria 
(Hesse et al., 2008):
•   The ethnographic fieldwork delineated the role of travel agencies promoting package travel: 
many agencies promoted their packages with party activities, ‘pub crawls’, drinking games and 
a clear focus on drunkenness and sex.
•   Over half (59 %) of package travellers drank 12 or more units of alcohol 6–7 days a week, 
compared with only about a quarter (27 %) of other travellers.
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•   A minority of holidaymakers (about 2.7 %) reported the use of illicit drugs. Whereas excessive 
alcohol use might be encouraged, there are sanctions against illicit drug use: tourist caught 
taking illicit drugs lose the wristbands that enable them to access bars and discos for free.
Young backpackers
There is a scarcity of data on drug use among young backpackers, but the available evidence 
suggests that it might be more common among them than among young people in the general 
population, both while they are at home and while they are travelling. One study recruited about 
1 000 young UK residents from backpacking hostels in Australia — a favourite destination for this 
population — to examine their drug use (Bellis et al., 2007).
The researchers reported an almost ninefold difference in past-year ecstasy use among the sample 
compared with young people in the general population of England and Wales (34 % vs. 4 %). 
Results also showed:
•   While still in their home country, over two-thirds had ever used cannabis (over a quarter using 
weekly); about half had used ecstasy (one in ten using weekly); about a third had used cocaine 
(about 4 % using weekly); and about a quarter had used amphetamine (about 4 % using 
weekly).
•   While in Australia, half had used cannabis (about a third using weekly); about a third had used 
ecstasy (one in ten using weekly); and about 7 % had used cocaine or amphetamine (about 1 % 
using weekly) (9). About 3 % of participants reported using ecstasy and cannabis for the first time 
while travelling.
When comparing the frequency of drug use while at home with that while travelling, three different 
patterns were identified: unchanged frequency of use, using more often while travelling and using 
less often while travelling:
•   Most users (about half of cannabis users and about two-thirds of ecstasy, cocaine and 
amphetamine users) reported that drug use frequency was unchanged compared with that in 
their home country.
•   Cannabis users were more likely to indicate an increase (28 %) rather than a decrease (16 %), 
whereas ecstasy, cocaine or amphetamine users recounted decreases more often than increases.
In summary, only a small proportion reported using a drug for the first time while travelling in 
Australia and most drug users reported an unchanged frequency of use compared with home. 
Cannabis users were more likely to increase rather than decrease their drug use, whereas users of 
ecstasy, cocaine or amphetamine were more likely to report a decrease rather than an increase in 
the frequency of use compared with their use at home.
(9)  The use of any illicit drug was higher among males, those who were surveyed in Sydney, those who had travelled 
without a partner or spouse, those who stayed in Australia for a longer time, those who spent a higher number of 
nights clubbing and/or those who drank alcohol or smoked tobacco daily.
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Young clubbers and partygoers
Several studies have shown that people who visit clubs, parties, music festivals and dance events 
are more experienced with the use of drugs than other young people (Measham et al., 2001; Van 
Havere et al., 2009, 2011). The combined use of alcohol and illicit drugs at party scenes is also a 
public health concern (Van Havere et al., 2011). Drug use among partygoers, however, varies 
widely based on music preference and venue choice (Calafat et al., 2008). A study assessing 
past-year drug use among visitors of music events in Belgium showed, for example, that, although 
alcohol was the most common drug used (92 %), the majority of respondents (52 %) reported 
having used at least one illicit drug (Van Havere et al., 2011). The majority of Goa partygoers (four 
out of five) reported having used at least one drug during the past year. Overall, cannabis was the 
most frequently used illicit drug during the past year (44 %), followed by ecstasy (19 %) and 
cocaine (17 %).
The proportion of those using drugs during electronic music dance events may vary widely, with 
studies reporting 10 % testing positive for drug metabolites (Gripenberg-Abdon et al., 2012), and 
half reporting the use of ecstasy during an event and using an average of five drugs at the same 
time (Fernandez-Calderon et al., 2011).
Ibiza and Majorca are two of the largest Balearic Islands. Despite their geographical proximity, 
however, the two islands offer different activities for their visitors. Ibiza, as described earlier, is 
famous for its nightlife and electronic music scene, whereas Majorca attracts holidaymakers mainly 
because of its warm weather and natural beauty. A study in 2007 compared drug use on Ibiza 
and Majorca among just over 3 000 young UK, German and Spanish visitors (Bellis et al., 2009; 
Hughes et al., 2009). Results included:
•   Visitors to Ibiza were more likely than visitors to Majorca to have used illicit drugs both in their 
home countries in the past year and while on holiday. For example, one-third of UK nationals in 
Ibiza reported using ecstasy (vs. 7 % in Majorca) and cocaine (vs. 9 %) at home, 20 % used 
cannabis (vs. 14 %) and 8 % used ketamine (vs. 2 %).
•   While on holiday, 54 % of UK nationals in Ibiza and 14 % in Majorca reported using any illicit 
drug: 44 % vs. 4 % reported using ecstasy, 34 % vs. 8 % cocaine, 20 % vs. 10 % cannabis, 
14 % vs. 2 % ketamine, and 5 % vs. 2 % amphetamine.
•   While on holiday in Ibiza compared with Majorca, 20.3 % vs. 12.4 % of UK nationals, 5.2 % 
vs. 4.2 % of Germans and 15.4 % vs. 9.5 % of Spaniards had used at least one illicit drug they 
had not used previously.
•   Whereas 95 % of all interviewees reported drinking at least some alcohol while on holiday, UK 
nationals were the most likely and Spanish nationals were the least likely to get drunk. Regular 
drunkenness (being drunk on five or more days a week) was reported by 61 % of UK nationals 
and 7 % of Spaniards in Majorca, and 53 % of UK nationals and 15 % of Spaniards in Ibiza.
Overall, among visitors in Ibiza the prevalence of drug use during this holiday period was higher 
than past-year prevalence at home for all drugs except cannabis, whereas among visitors in 
emcdda.europa.eu
12Travel and drug use in Europe: a short review
Majorca there was a detected increased use of only alcohol and tobacco. A significant proportion 
of the visitors, especially from the UK, had used a new drug while away from home.
The results from the same team of researchers’ earlier studies in 1999 and 2002 show that those 
who used drugs in Ibiza were more likely to indicate excessive use than when using in the United 
Kingdom (Bellis et al., 2003): about half of cannabis users and ecstasy users, and about a quarter 
of cocaine users — especially if they had been to Ibiza before — reported using on five or more 
days a week. The prevalence of drug use and the types of drugs used among young visitors to 
Ibiza reported in 2009 are similar to those reported from these earlier studies, indicating that Ibiza 
is an established location for drug use related to extensive clubbing and partying.
Drug use among casual workers at international nightlife resorts
A study compared the drug use of young UK tourists working in bars and nightclubs at an international 
nightlife resort in Ibiza with that of individuals visiting the island solely for the purpose of vacationing (Hughes 
et al., 2004).
Workers were more likely than visitors to have used drugs at home during the past year. For example, about 
80 % of workers reported using ecstasy (vs. 40 % of visitors), cocaine (vs. 33 %) and cannabis (vs. 46 %) at 
home, and 51 % used amphetamine (vs. 16 %) and ketamine (vs. 9 %).
While on the island, a higher proportion of workers than visitors reported drug use: 91 % vs. 41 % reported 
using ecstasy, 87 % vs. 22 % cocaine, 82 % vs. 35 % cannabis, 71 % vs. 7 % ketamine, and 44 % vs. 7 % 
amphetamine. Some of these differences, however, might be explained by the different length of the stay; the 
average stay on the island was 100 days among workers and 7 days among visitors.
The average number of different illegal drugs used was higher among workers than among visitors (5 vs. 2 
both at home and on the island).
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5. Risks associated with drug use while travelling
The literature accessed for this publication identifies several risks that drug-using travellers take: 
health risks, risks related to personal safety, legal risks and those related to drug injecting. While 
many of the risks are general risks related to drug use, there are some that are specific to the 
phenomenon of travelling, for example the risks to the local communities affected by drug-using 
visitors, which are also discussed in this section. The combination of drug use with alcohol, 
especially with excessive drinking, may increase some of the risks described below.
Health risks
Being under the influence of drugs while on holiday may result in consequences ranging from minor 
medical conditions to major physical and mental health problems or death. Minor medical 
conditions include sickness, diarrhoea, hangovers, headaches and sunburn (10) (Elliott et al., 1998). 
Dehydration may result from overexposure to the sun, diarrhoea, vomiting and excessive 
perspiration without adequate hydration while using stimulants and dancing for a prolonged period 
of time. The Spanish focal point gave an account of cases that were handled by hospital 
emergency services in Ibiza in 2010:
•   Of a total of 805 medical emergencies, 33 % were patients from other countries, with this 
proportion peaking in the summer months.
•   The majority of individuals were between the ages of 20 and 30, and 68 % were female.
•   Drugs played a major role in these hospital emergencies: 41 % of the interventions were due to 
cocaine use, and 26 % were due to amphetamines or designer drugs.
Consuming drugs of unknown purity in an unfamiliar environment may lead to unwanted 
physiological and cognitive damages or even overdose. This may be a particular risk for travellers 
who have no previous experience of the drugs they use while away. To prevent such consequences, 
some drug users may opt to use drugs they consider safer, such as cannabis, which is seen by 
some as a drug that allows users to ‘stay in control’ (Bellis et al., 2007).
While travelling, some users may use drugs excessively or consume a wider array of substances 
than they do at home, or use them in combination or while drinking alcohol excessively (Bellis et 
al., 2003). Although they may revert to different patterns of use when returning home, the 
cumulative effect of consuming large amounts of a range of substances — in some cases nightly, for 
possibly as long as several weeks — may exacerbate adverse physical and physiological effects of 
the drugs.
Being under the influence of drugs or alcohol while travelling on holiday may lead to unprotected 
sex, the consequences of which include acquiring or spreading sexually transmitted diseases. 
(10) From failing to use sunscreen or falling asleep in the sun under the influence of drugs.
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Although sexual activity may diminish among those who use drugs while travelling, there are 
indications that sexual risks increase among young travellers under the influence of drugs and/or 
alcohol. A study assessing sexual risk among tourists found that 34 % of those who engaged in 
sexual activities while on vacation did so without using condoms, and unprotected sex was 
associated with using illegal drugs (Downing et al., 2011). For example, they may engage in 
casual, unprotected sexual activity with several new partners (Hughes et al., 2009) and the 
involvement of drugs in so-called ‘date rapes’ is well established (Jansen and Theron, 2006).
Risk related to personal safety
Being intoxicated with drugs or being drunk can lead to compromised personal safety. In studies of 
young holidaymakers in Spain (Hughes et al., 2008, 2009, 2011), up to 11 % of respondents (21 % 
of UK males in Majorca) reported being involved in fights — the majority against strangers of their 
own nationality. In addition, 13 % reported being victims of unintentional injuries and up to 11 % 
were robbed. Being involved in these incidents had a high correlation with regular drunkenness but 
also with drug use while on holiday: 92 % of those who reported being in a fight were under the 
influence of alcohol, and 9 % had been using drugs. In addition, many times the victims of fights 
were also under the influence of alcohol or drugs. The Spanish National report recounts the 
practice of ‘balconing’, when drunken young people climb from one hotel room to another or jump 
off from hotel balconies to swimming pools — an obviously dangerous activity.
An inability to handle dangerous situations, such as overcrowding at large music festivals, may be 
another consequence of drug or alcohol use while travelling. For example, the annual Love Parade 
was a popular event in Duisburg, Germany, for over 20 years, until its final year in 2010, when a 
stampede caused the death of 21 people and led to the hospitalisation of 473 who were injured 
— 30 % of whom tested positive for drug metabolites (Ackermann et al., 2011).
Legal risks
Violation of the destination country’s drug laws is another issue for drug-using travellers (Uriely and 
Belhassen, 2006). Young tourists may not consider purchasing drugs as risky, especially in drug-
related destinations, perhaps thinking that drug use is tolerated among tourists and that they will 
not be arrested by local police or when smuggling drugs in and out of the country.
Risks related to injecting drug use
Bridge populations are people who connect groups that have lower infection prevalence to 
high-prevalence groups, which otherwise would be separated either by geographical distance or 
by the separation of social and risk networks. Injecting drug users who travel — such as those who 
move between eastern and central European countries — may form geographical bridges between 
higher and lower HIV/hepatitis C virus prevalence groups (Gyarmathy and Neaigus, 2005). Some 
of the injecting drug users in a drug treatment programme in Slovenia (Kostnapfel et al., 2011) 
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reported travelling to distant locations, such as Asia or America. Finding drugs at the destination 
was regarded as easy, but difficulties in accessing sterile injecting equipment prompted them to 
share syringes with unknown drug users.
Risks to local communities
Tourism brings income to the host countries. For example, in 2009 Spain was ranked second in the 
world as regards revenues from international tourism (UNWTO, 2012), and both Spain’s eastern 
Mediterranean coast and southern Spain specialise as holiday destinations for young people who 
associate tourism with recreational nightlife. Travel and related drug use, however, can cause 
problems at the destination, including public nuisance and changes in the way of life of locals. For 
example, on the island of Ibiza, 80 % of 17-year-olds have already been to a discotheque, even 
though they would not be allowed to do so by law (Villar, 2008). The Greek National report 
presented the results of a study in the town of Pythagorion on the island of Samos, which revealed 
that local residents perceived drug use as worsening as a result of tourism.
Local public health and social services are put under pressure by dealing with the effects of drugs 
on some users. For example, the national focal point in Spain recounted that private medical 
insurance policies do not cover the expenses arising from drug-related problems, so these patients 
are delivered to public hospitals in the event of drug-related emergencies. In these hospital settings, 
the language barrier often hinders communication with the patent and thereby diagnosis, making 
medical caretaking longer, or — if international calls or interpreters are required — very costly. 
Complications may happen while still in the hospital as a result of scant or misinterpreted 
information from the patient. Difficulties after being released from the hospital include seeking 
money or support to be able to return to the home countries (11).
Local communities may complain about public nuisance related to drug use, especially drug 
tourism. In Prague, Czech Republic, special healthcare facilities exist for short-term detoxification of 
people involved in public nuisance as a result of being intoxicated with psychoactive substances. 
Foreigners made up 1 011 out of 12 720 individuals (7.9 %) treated at sobering-up stations in 
2010. In relation to public nuisance related to drug tourism, two Dutch municipalities near the 
border closed all their coffee shops and, in Maastricht, five coffee shops were relocated from the 
town centre to the peripheries, to make them less easy for visitors from across the Belgian and 
German borders to access (Monshouwer et al., 2011). In addition, Maastricht and other border 
municipalities have introduced a number of measures to curb drug tourism related to coffee shops, 
including the restriction of sales to foreign nationals (12). The Dutch national focal point reports that 
the Dutch government reserved EUR 3.3 million for municipal pilot projects to evaluate the effect of 
these new measures to combat public nuisance related to drug tourism. One of these projects 
evaluated the effect of the new restrictions in Roosendaal and Bergen, towns located at the Belgian 
border, and found that 6 months after the closure of the coffee shops the number of foreign drug 
tourists had diminished by 90 % and the reported public nuisance and street trading had declined 
(11) For more information: www.irefrea.org/uploads/PDF/informe%20urgencias.pdf
(12) http://curia.europa.eu/jcms/upload/docs/application/pdf/2010-12/cp100121en.pdf
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considerably. The National report contrasted border towns with Amsterdam, where locals feel that 
tourists do not cause much public nuisance. Therefore, instead of establishing a closed coffee shop 
system catering only to Dutch nationals, Amsterdam’s mayor called for regulating cannabis 
cultivation. Certain districts such as the Amsterdam quarter of De Baarsjes, however, implemented a 
special street security system paid for by the coffee shops with the aim of maintaining order in 
public spaces by addressing antisocial behaviour and cleaning the streets daily.
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6. Potential for prevention interventions
Preventing drug use and associated risks among travellers raises two main considerations. First is 
the question of whether prevention efforts should take place in the home country or in the 
destination country: in both locations, it is difficult to find the appropriate target group, as not all 
travellers use drugs and not all drug users travel. Second, prevention interventions for different 
target groups of travellers require different strategies and involve different messages. Therefore, 
much of the currently available prevention strategies may be restricted to information provision, 
while other forms of prevention, such as environmental approaches or policing, may also be 
useful.
Illicit drug use and drinking alcohol in nightlife settings may carry several risks. As these substances 
are often used in combination, preventive measures in recreational settings should aim to address 
them together. As the EMCDDA (2012) paper on responding to drug use and related problems in 
recreational settings concludes, the traditional approach of information provision must be replaced 
by a combination of prevention, harm reduction, legislation and law enforcement efforts. The 
publication also underlines the importance of environmental strategies, including but not limited to 
the role of nightlife staff and the physical context in which drug use may take place.
As most of the young people who use drugs while travelling have also used drugs at home, 
interventions aimed at them should take advantage of their existing levels of awareness and beliefs 
(Elliott et al., 1998). These could involve prevention materials at the destinations and peer educators 
to increase the credibility of the messages. For these initiatives to be successful, collaboration is 
needed between health authorities and the stakeholders in the travel industry, both in the countries 
of origin and at the destination locations. In addition, interventions should take into account that 
there are different traveller populations with different substance use behaviours and different needs, 
and these differences should be addressed appropriately. For example, certain drugs may cause 
feelings of euphoria, whereas the use of others may result in aggression. Given this, prevention 
interventions may choose to focus on drugs such as cocaine (alone or in combination with alcohol) 
in order to decrease violence in the nightlife environment (Bellis et al., 2003).
According to the Spanish National report, some large discotheques have engaged companies that 
provide private medical services. This enables clubs to deal effectively with emergencies due to 
excessive drinking or drug use that do not require hospitalisation.
Electronic media, such as the Internet and text messaging, are other promising venues for 
interventions. Information on the effects of drugs that are available at different travel destinations 
could be placed on social networking websites and forums used by travellers, and on websites that 
advertise events where a sizeable proportion of attendees are expected to use drugs. Travellers 
could sign up to a service disseminating drug-related information by text messages. In addition, 
such information should also be available at airports and at travel agencies, and at stores that are 
used by those planning to travel, particularly to drug-related destinations (Uriely and Belhassen, 
2006). All these methods should also be used to ensure that travellers who use drugs at their 
destination are aware of several aspects of drug use, including the local policy and law related to 
drugs, and access to local emergency and care services.
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Drug services should provide information for their clients who travel, to explain the legal and health 
risks involved in using drugs abroad, how to get help in an emergency situation, and the location 
of needle exchanges. These services also should inform their clients who intend to travel about the 
procedures for taking supplies of their substitution medications and injecting equipment with them 
(Kostnapfel et al., 2011).
Further research and needs assessments could identify a profile of those who are likely to use drugs 
while travelling and the risks they may take, and information could be specifically developed for 
them (Bellis et al., 2007). Such tailored approaches have been found to be much more effective 
than the provision of ‘one-size-fits-all’ information that ignores the specific needs and characteristics 
of different target groups (EMCDDA, 2008).
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7. Conclusions
This publication has examined drug use in the context of travelling, examining some data on 
populations who travel, the destinations they travel to, the prevalence of drug use among different 
youth travelling populations, the risks involved in using drugs while travelling, and the potentials for 
prevention. Its goal is to increase the interest in this topic both in terms of research and of 
developing adequate responses to problems related to drugs and travel.
One of the consequences of the growth of travel in recent decades is an increase in the number of 
young people travelling for longer periods of time. Travellers are, however, not a homogeneous 
group. There are subgroups of travellers, based on, for example, their travelling style (such as 
backpackers on a low budget) or their risk profiles (such as problem drug users or those visiting 
drug-related destinations).
Drug use is more common among some groups of travellers and at some destinations. For example, 
drug use among backpackers is higher than among the general population, and drug use among 
partygoers in Ibiza is more common than among holidaymakers in Majorca. Certain travel 
destinations across Europe have a reputation of having a wide availability of a range of drugs. 
These include party locations, electronic music festivals and the nightlife scene on certain 
Mediterranean islands. While some countries have reacted with legal regulations to curb the public 
nuisance related to loud music and large numbers of unruly people under the influence of an array 
of illicit substances, these sanctions often led to an internationalisation of such parties. For example, 
it is common in the border areas of several western European countries to cross the border for a 
night or a weekend of partying, including illicit drug use.
Other destinations where drugs are available include coffee shops in the Netherlands, where 
patrons can buy cannabis. In the Czech Republic methamphetamine, a drug otherwise relatively 
rarely available in most of Europe, is a rather common illicit drug that may attract drug users from 
neighbouring countries.
Several risks are associated with taking drugs while travelling, ranging from minor medical 
conditions to major health problems. While some of these risks are related to drug use in general, 
others are specifically liked to the phenomenon of travelling. Using drugs of an unknown quality, 
which is a risk both at home and while travelling, may lead to physiological damages or overdose. 
Excessive drug use, even for a short time, may exacerbate any adverse physical and physiological 
effects of drug use. Travellers who use drugs may also violate the drug laws of the host country 
regarding purchase, possession, consumption and smuggling. Sexual activity while under the 
influence of drugs carries the risk of acquiring and/or transmitting sexually transmitted diseases, 
and sharing injecting equipment may contribute to the spread of HIV, hepatitis C virus and other 
blood-borne infections. Preventing these risks requires collaboration between health authorities and 
stakeholders in the tourist industry.
Local communities may also be negatively affected by drug-using travellers. Although travel and 
tourism bring income to the host countries, small populations in tourist destinations may have a 
large influx of visitors who may have very different cultural norms. This may obviously have several 
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implications for local policies and services. For example, some visitors’ drug use may lead to 
antisocial behaviour and public nuisance. There may also be an increase in the number of people 
requiring health and social services. These situations put pressure on the local law enforcement, 
health and social services. There is, however, little information about how drug-using tourists affect 
local communities across different countries and locations within Europe.
Travel, of course, is not necessarily associated with illicit drug use. Rather, those who travel behave 
similarly to the way they behave at home: those who use drugs at home are more likely to use 
drugs while away and those who are abstinent at home tend to remain abstinent while travelling. In 
addition to such personal background behaviour, drug use during travel may increase, decrease or 
stay the same as it was at home, depending on the destination, the reasons for visiting it and the 
availability of drugs there.
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